Lumexa Imaging (NASDAQ:LMRI) Shares Gap Up Following Analyst Upgrade

Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) gapped up prior to trading on Monday after Raymond James Financial upgraded the stock from an outperform rating to a strong-buy rating. The stock had previously closed at $10.80, but opened at $11.72. Raymond James Financial now has a $23.00 price target on the stock. Lumexa Imaging shares last traded at $11.63, with a volume of 116,667 shares traded.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Lumexa Imaging stock. Assetmark Inc. purchased a new stake in shares of Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 1,957 shares of the company’s stock, valued at approximately $36,000.

Lumexa Imaging Stock Up 8.5%

About Lumexa Imaging

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).